Pancreatic Cancer

PancreasA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
PancreasRASolute 305: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (Modified FOLFIRINOX or Gemcitabine Plus Nab-Paclitaxel) With or Without Zoldonrasib (RMC-9805) as First-line Treatment in Patients With Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
Anus, Breast, Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Other Digestive Organ, Pancreas, Phase I, Rectum, Small Intestine, Stomach, ThyroidAn Open-label, Phase 1a/b, Multicenter Study of ZL-6201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy in Participants With Sarcoma and Selected Solid Tumors
Esophagus, Pancreas, StomachA Phase 1a/b, Multicenter, Open-label, First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Colon, Lung, Other Digestive Organ, Pancreas, Phase IPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies